Stress and the progression of the developmental hypothesis of schizophrenia

British Journal of Psychiatry

Volumn 181, Issue NOV., 2002, Pages 363-365

  Cotter, David ^a   Pariante, Carmine M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

BIPOLAR DISORDER; EDITORIAL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHESIS; MAJOR DEPRESSION; NEUROPATHOLOGY; NEUROPSYCHIATRY; PATHOGENESIS; SCHIZOPHRENIA; STRESS;

BIPOLAR DISORDER; DEPRESSIVE DISORDER; GLUCOCORTICOIDS; HUMANS; SCHIZOPHRENIA; STRESS;

EID: 0036849407     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.181.5.363     Document Type: Editorial

References (35)

1. Altshuler, L. L., Bartzokis, G., Grieder, T., et al (1998) Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: An MRI study demonstrating neuroanatomic specificity. Archives of General Psychiatry, 55, 663-664.
2. Bauer, M. E., Vedhara, K., Perks, P., et al (2000) Chronic stress in caregivers of dementia patients is associated with reduced lymphocyte sensitivity to glucocorticoids. Journal of Neuroimmunology, 103, 84-92.
3. Benes, F. M., Todtenkopf, M. S. & Kostoulakos, P. (2001) GluR5,6,7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives. Hippocampus, II, 482-491.
4. Clouston, T. S. (1891) The Neuroses of Development. Edinburgh: Oliver & Boyd.
5. Cotter, D., Mackay, D., Landau, S., et al (2001a) Glial cell loss and reduced neuronal size in the anterior cingulate cortex in major depressive disorder. Archives of General Psychiatry, 58, 545-553.
6. _, Pariante, C. M. & Everall, I. (2001b) Glial cell abnormalities in major psychiatric disorders: The evidence and implications. Brain Research Bulletin, 55, 585-595.
7. _, Mackay, D., Chana, G., et al (2002) Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cerebral Cortex, 12, 386-394.
8. Crossin, K. L., Tai, M. H., Krushel, L. A., et al (1997) Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation. Proceedings of the National Academy of Sciences of the USA, 94, 2687-2692.
9. De Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., et al (1998) Brain corticosteroid receptor balance in health and disease. Endocrine Reviews, 19, 269-301.
10. Eastwood, S. L. & Harrison, P. J. (2001) Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a western blot study of synaptophysin, GAP-43, and the complexins. Brain Research Bulletin, 55, 569-578.
11. Evans, D. L., Burnett, G. B. & Nemeroff, C. B. (1983) The dexamethasone suppression test in the clinical setting. American Journal of Psychiatry, 140, 586-589.
12. Harrison, P. J. (1999) The neuropathology of schizophrenia: A critical review of the data and their interpretation. Brain, 122, 593-624.
13. Holsboer-Trachsler, E., Buol, C., Wiedemann, K., et al (1987) Dexamethasone suppression test in severe schizophrenic illness: Effects of plasma dexamethasone and caffeine levels. Acta Psychiatrica Scandinavica, 75, 608-613.
14. Ismail, K., Murray, R. M., Wheeler, M. J., et al (1998) The dexamethasone suppression test in schizophrenia. Psychological Medicine, 28, 311-317.
15. Keshavan, M. S., Haas, G. L., Kahn, C. E., et al (1998) Superior temporal gyrus and the course of early schizophrenia: Progressive, static or reversible? Journal of Psychiatric Research, 32, 161-167.
16. Lawrie, S. M., Whalley, H., Byrne, M., et al (2000) Brain structure change and psychopathology in subjects at high risk of schizophrenia. Schizophrenia Research, 41, 11.
17. Lewis, S. W. & Murray, R. M. (1987) Is schizophrenia a neurodevelopmental disorder? BMJ, 295, 681-682.
18. Lucassen, P. J., Muller, M. B., Holsboer, F., et al (2001) Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. American Journal of Pathology, 158, 453-468.
19. Mathalon, D. H., Sullivan, E. V., Lim, K. O., et al (2001) Progressive brain volume changes and the clinical course of schizophrenia in men: A longitudinal magnetic resonance imaging study. Archives of General Psychiatry, 58, 148-157.
20. McCarley, R. W., Wible, C. G., Frumin, M., et al (1999) MRI anatomy of schizophrenia. Biological Psychiatry, 45, 1099-1119.
21. Pantellis, C., Velakoulis, D., Suckling, J., et al (2000) Left medial temporal lobe volume reduction occurs during the transition from high risk to first episode psychosis. Schizophrenia Research, 41, 35.
22. Pariante, C. M. & Miller, A. H. (2001) Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment. Biological Psychiatry, 49, 391-404.
23. _, Makoff, A., Lovestone, S., et al (2001) Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporter. British Journal of Pharmacology, 134, 1335-1343.
24. Pasamanick, B., Rodgers, M. E. & Lilienfield, A. M. (1956) Pregnancy experience and behaviour disorder in children. American Journal of Psychiatry, 112, 613-618.
25. Rajkowska, G., Miguel-Hidalgo, J. J. & Wei, J. (1999) Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry, 45, 1085-1098.
26. _, Halaris, A. & Selemon, L. D. (2001) Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biological Psychiatry, 49, 741-752.
27. Rosoklija, G.,Toomayan, G., Ellis, S. P., et al (2000) Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders. Archives of General Psychiatry, 57, 349-356.
28. Sapolsky, R. (1996) Stress, glucocorticoids, and the damage to the nervous system: The current state of confusion. Stress, 1, 1-11.
29. _ (2000) The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death. Biological Psychiatry. 48, 755-765.
30. Sharma, R. P., Pandey, G. N., Janicak, P. G., et al (1988) The effect of diagnosis and age on the D5T: A metaanalytic approach. Biological Psychiatry, 24, 555-568.
31. Southard, E. E. (1915) On the topographical distribution ofcortex lesions and anomalies in dementia praecox with some account of their functional significance. American Journal of Insanity, 71, 603-671.
32. Tandon, R., Mazzara, C., DeQuardo, J., et al (1991) Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome. Biological Psychiatry, 29, 953-964.
33. Thompson, P. M., Vidal, C., Giedd, I. N., et al (2001) Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proceedings of the National Academy of Sciences of the USA, 98, 11650-11655.
34. Webster, M. J., O'Grady, J., Orthmann, C., et al (2000) Decreased glucocorticoid receptor mRNA levels in individuals with depression, bipolar disorder and schizophrenia. Schizophrenia Research, 41, 111.
35. Weinberger, D. R. (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry, 44, 660-669.